Most Freedom to Operate search failures don’t happen because the analyst missed an obvious patent. They happen because the analyst applied the wrong mental model to the job entirely.
An FTO search is not a prior art hunt. It’s not an invalidity exercise. It’s a forward-looking risk assessment against live, enforceable patent rights. When analysts carry habits from novelty or invalidity work into FTO, the errors tend to be systematic, not accidental. They’re baked into the process before the first search string is written.
At GreyB, we’ve worked on FTO matters across the pharmaceutical, biologics, wireless technology, and manufacturing-heavy industries. The gaps we see most often aren’t random. They cluster around the same eight failure points and surface most often in high-stakes launches, where the cost of a missed reference is highest.
This guide walks through those failure points, the cases behind them, and the analyst mindset that separates a defensible FTO report from one that creates more legal risk than it resolves.
What a Freedom to Operate Search Actually Is (and What It Isn’t)
A Freedom to Operate search (also called a clearance search or right-to-use analysis) determines whether a product, process, or technology can be commercialized without infringing third-party patent rights.
That’s different from a patentability search, which assesses novelty. It’s different from an invalidity search, which challenges whether a patent should have been granted at all. FTO work focuses on one question: Can a live patent owner assert rights against the client?
That single question changes the entire framework. Dead patents, abandoned applications, and expired references matter far less here. The analyst isn’t looking backward at the prior art landscape. They’re mapping active, enforceable rights to determine whether they block a commercial path.
The stakes justify that focus. An overlooked infringement risk can lead to injunctions, damages, or expensive design changes after a product has already launched. In high-value markets, a single missed reference can derail a product launch or reshape a licensing negotiation.
Get a Second Opinion on Your FTO Coverage
The Eight Mistakes That Compromise FTO Work
Applying a Strict 20-Year Filing Cutoff
FTO searches focus on active and pending patents, which makes a 20-year window a reasonable starting point. It shouldn’t be a hard rule.
Patent life can be extended through patent term adjustments or patent term extensions. In one case GreyB reviewed, a patent filed decades earlier remained enforceable well beyond what its filing date suggested. Administrative delays during prosecution had significantly extended the enforceable term. The patent covered a commercially important biologic formulation and was directly relevant to the client’s launch strategy. A strict 20-year cutoff would have removed it from the search set entirely.
This issue is most common in pharmaceutical and biologic matters. Standard search windows are still useful for narrowing the initial dataset, but they should never replace a legal status review. For WIPO applications, analysts should also account for the 30-month national phase window.
Relying on Dependent Claims to Gauge Risk
FTO analysis should start with independent claims. They define the broadest scope. Dependent claims narrow the embodiments but don’t reduce the risk created by the independent language above them.
In one formulation patent we reviewed, the dependent claims focused on a narrow species that appeared commercially irrelevant. A closer reading of the independent claim showed that it broadly covered the formulation category associated with the client’s product. The dependent claims had created the impression that coverage was limited. The independent claim language created the real risk.
This pattern appears often in biotechnology, pharmaceutical, and formulation-based FTO work. Analysts should assess the scope from the independent claims first, then evaluate whether the dependent limitations actually reduce the infringement exposure, not assume they do.
Overlooking Composition of Matter Patents
Composition of matter patents claim chemical structures, formulations, or biological sequences. They’re often foundational patents in a technology space, and they rarely name the commercial product directly.
In one biologic FTO matter, a relevant formulation patent didn’t mention the product name, common synonyms, or the exact biological sequence tied to the client’s molecule. At first glance, it looked unrelated. A broader review showed the patent covered a family of antibodies connected to the same composition of matter portfolio. The claims focused on formulation behavior and protein stability, not the biologic by name.
If the analyst had relied only on direct keyword matching or product-name searching, the reference would have been excluded. In biologics and antibody-related FTO work, patent families often divide coverage across composition claims, formulation claims, dosage claims, and manufacturing claims. Each needs to be reviewed.
Searching Outside the Client’s Jurisdictions
FTO searches are geographic by nature. A patent granted in one country provides no rights in another. Including references from jurisdictions outside the client’s commercial scope adds noise to the report and can misrepresent the actual risk picture.
Analysts should confirm target jurisdictions at the start of every project and apply those filters consistently throughout the search. If a highly relevant patent appears outside the target jurisdictions, it can be flagged separately as a contextual observation, but it shouldn’t be treated with the same weight as an in-scope threat.
Treating Legal Status as Binary
Only active patents, granted patents, and pending applications are typically relevant in FTO analysis. Some clients also want recently expired patents reviewed, including those that expired because of missed maintenance fees or procedural issues. Analysts should confirm this requirement before excluding those references.
In jurisdictions that allow patent revival, a patent listed as inactive today can become enforceable again. That means a reference that looks safely expired can still carry commercial risk. More on this in the section below.
Reporting Applications When Granted Members Exist
Analysts should always check whether a patent application has a granted family member in the target jurisdictions. If a granted version exists, the granted claims should take priority. Granted claims have passed examination and are typically narrower than what was originally applied for. Presenting the application version when a granted version exists gives an inaccurate picture of the actual claim scope.
Using Outdated Claim Versions in Pending Applications
Claims in pending applications change during examination. An analyst who reviews the claims at the time a reference enters their search set may be working with language that has since been amended. Before finalizing the analysis, the latest available claims should be verified to confirm whether overlap with the client’s product still exists.
Skipping Inventor and Assignee Verification
Before reporting a reference, analysts should confirm who owns it. If a reference belongs to the client, it doesn’t create a commercial threat. Those references can still be shared separately as background context, but they shouldn’t sit in the main risk tier without a note on ownership. Assignee verification also helps identify whether the patent holder is a practicing entity, a licensing-focused company, or an assertion vehicle, which affects how the threat should be weighted.
The Quietly Revivable Patent Problem
One of the more subtle FTO risks involves patents that look expired but aren’t safely closed.
Most analysts apply an “alive” filter and move on. That works for patents that have completed their full term. It misses a category that matters more than it appears to: patents that lapsed because of missed maintenance fees or delayed responses to office actions.
In some jurisdictions, these patents can be revived. A patent listed as inactive in a database today could become enforceable again if the owner corrects the procedural lapse. If that patent overlaps with the client’s product, it still carries commercial risk.
The practical recommendation is to run a supplementary search covering patents that expired within the last two to three years due to fee or procedural issues. Legal status filters and jurisdiction-specific database tools can help identify these references. The analyst should flag relevant ones with a note on revival eligibility in the jurisdiction rather than treating them as closed risks.
Get a Second Opinion on Your FTO Coverage
Why the Best FTO Analysts Think Like Consultants
Identifying threats is the baseline of FTO work. The analysis that actually helps a client is what comes after the identification.
A Tier I and Tier II list tells a legal team what to look at. It doesn’t tell them what the overlap means, how severe it is, whether it’s arguable, or what options still exist. That context is what turns a search output into a decision-support document.
A strong FTO report explains why a patent creates risk, which product features overlap with the patent claims, whether the overlap is complete or arguable, whether the threatening patent may itself face invalidity risks, and whether structural differences in the client’s implementation reduce the practical infringement exposure.
In one FTO matter GreyB handled, an analyst identified a high-risk patent with substantial overlap against the client’s product configuration. The overlap looked strong enough to represent a direct commercialization barrier. Instead of stopping at claim mapping, the analyst extended the review and identified earlier prior art that potentially challenged the validity of the threatening patent. The analyst also reviewed secondary references that introduced structural limitations not present in the client’s implementation.
Those distinctions narrowed the practical infringement exposure and gave the legal team multiple strategic options. The client could evaluate possible invalidity arguments, potential design changes, and the remaining commercial impact of the patent before making a business decision. That’s the difference between a list of threats and an actual strategic input.
Preliminary strategic guidance that belongs in a strong FTO report can include identifying prior art that could challenge a threat patent, suggesting design modifications that reduce overlap risk, assessing whether the patent owner is a practicing company or an assertion entity, and reviewing the remaining patent term to understand how long the risk window actually extends.
Freedom to Operate Across High-Stakes Technology Areas
The same principles apply across all FTO work, but the emphasis shifts depending on the technology area.
In pharmaceuticals and biologics, the composition of matter landscape, patent term adjustments, and formulation claim breadth require particular attention. In wireless technologies, standard-essential patent exposure adds a layer of analysis that doesn’t apply in most other fields. In manufacturing-heavy industries, process patents can create infringement risk that product patents wouldn’t capture alone.
The judgment required to navigate these differences develops through project experience, not through applying a checklist. Analysts who review their methods regularly, compare outcomes across projects, and seek feedback from senior team members build the kind of calibrated judgment that holds up in high-value FTO matters.
How Patent Landscapes Affect FTO Methodology
Patent landscapes don’t stay fixed. Assignees shift portfolios between entities. Prosecution strategies change claim scope mid-examination. Jurisdictions update their legal standards for patent term and revival. AI-assisted search tools continue to change how analysts approach database coverage and query construction.
Strong FTO work stays current with these shifts while maintaining discipline in the core methodology. A search strategy that was well-designed two years ago may need adjustment for the same product today. The analyst’s job isn’t to run a fixed process. It’s to apply sound judgment within a process that adapts to what the current landscape actually looks like.
Most FTO gaps that surface in litigation or during diligence were gaps that existed in the original search methodology, not gaps in the patent databases. They come from applying the wrong filter logic, the wrong claim reading strategy, or the wrong scope assumption. Each of the eight failure points described above represents a place where methodology, not effort, is the variable.
Final Thoughts
Every FTO search starts with the same question: Does this product have a clear path to market?
The answer is rarely a clean yes or no. It’s a risk map. Some references create real barriers. Some create an arguable overlap. Some look threatening until the claim language is read carefully, and some look harmless until the composition of matter landscape is reviewed properly. The job isn’t to return a verdict. It’s to give the people making commercialization decisions an accurate picture of what’s actually in front of them.
The problem is that most FTO work gets evaluated too late. By the time a gap surfaces, the product is deep in development, the launch timeline is fixed, and the options that existed at month three are gone by month eighteen. Design modifications cost more. Licensing negotiations happen under pressure. Invalidity arguments get built in a hurry.
The searches that hold up under that pressure aren’t the ones that cover more databases. They’re the ones that started with the right methodology: correct claim reading, proper legal status verification, full composition of matter coverage, and jurisdiction filters that match the actual commercial plan.
If you’re currently looking at a product pipeline and trying to decide whether the FTO work already done is thorough enough, that instinct is worth following. The questions worth asking are specific ones. Were independent claims assessed before dependent ones? Were patents with term adjustments included? Were the composition of matter portfolios reviewed beyond direct keyword matches? Was legal status verified for recently expired references in revival-eligible jurisdictions?
If any of those answers are uncertain, the search may have gaps that aren’t visible yet. The time to find them is before the launch decision is made, not after.
If you’re assessing FTO coverage for a product entering a complex patent landscape or reviewing work done by another team before a high-stakes decision, fill out the form, and we’ll tell you what a second-pass review would actually cover.
Get a Second Opinion on Your FTO Coverage
Questions IP and Legal Teams Ask About FTO Search
Q: When should an FTO search be commissioned?
FTO searches are typically requested before a product launch, entering a new market, licensing discussions, or major manufacturing investments. The earlier the search is done, the more options remain open. A late-stage FTO that identifies a blocking patent after significant development investment leaves few good choices.
Q: How is an FTO search different from a freedom-to-operate opinion?
An FTO search is investigative work that identifies active patents that could potentially cover a product or process. An FTO opinion is the legal analysis built on top of that search, typically prepared by patent counsel, that reaches a conclusion on infringement risk and advises on commercial strategy. The search informs the opinion but doesn’t replace it.
Q: Why can’t we just use the last 20 years as a filing window?
Patent term adjustments and extensions can keep patents enforceable beyond the standard 20-year term, particularly in pharmaceuticals and biologics. A strict filing cutoff can exclude references that are still legally active. The 20-year window is a useful starting point for narrowing a dataset, not a substitute for verifying current legal status.
Q: Should we focus on independent claims or dependent claims when assessing risk?
Independent claims always come first. They define the broadest scope of the patent. Dependent claims narrow the embodiments, but the risk created by the independent language above them remains. An analyst who evaluates risk based on the narrow dependent claims without reading the independent claim is likely underestimating the threat.
Q: What does it mean when a patent expires due to missed maintenance fees?
In some jurisdictions, a patent that lapsed because of missed maintenance payments can be revived if the owner corrects the lapse. That means a patent showing as inactive in a database may still carry risk. Analysts should flag patents that expired in the last two to three years due to fee or procedural issues and note the revival status in the relevant jurisdiction.
Q: What makes an FTO report actionable rather than just informative?
An actionable FTO report explains why each identified patent creates risk, how strong the overlap is, whether the overlap is complete or arguable, and what strategic options exist. That might include prior art that challenges the threatening patent, design modifications that reduce overlap, or an assessment of the patent owner’s enforcement posture. A list of threat references without that context leaves the legal team with incomplete information for a commercialization decision.
Q: How should we think about jurisdictions in an FTO search?
FTO analysis is jurisdiction-specific. A patent that creates risk in one country may have no legal effect in another. Analysts should confirm the client’s target markets at the start of the project and apply consistent jurisdiction filters throughout. Relevant patents outside the target jurisdictions can be noted separately, but they shouldn’t be weighted as primary threats.
Q: How do GreyB analysts handle composition of matter patents in biologic FTO work?
In biologics and antibody-related work, patent families often split coverage across composition claims, formulation claims, dosage claims, and manufacturing claims. GreyB analysts review the full composition of matter landscape, not just references that directly name the client’s product or biological sequence. Relying on keyword matching or product-name searching misses the foundational patents that carry the most commercial weight.
Q: What’s the risk of reporting an application when a granted version exists?
Granted claims have passed examination and are typically narrower than the original application claims. Presenting the application version when a granted version exists gives an inaccurate view of the actual claim scope. Analysts should always check for granted family members in the target jurisdictions and prioritize those for claim-level analysis.
Q: How often should FTO searches be updated?
A one-time FTO search is a point-in-time snapshot. Patent landscapes shift as new applications are filed, prosecution advances, and assignees transfer portfolios. For products with long development timelines or for markets where competitive patent activity is high, the original search should be refreshed before launch, especially if more than 12 to 18 months have passed since the initial analysis.
Most FTO gaps don’t surface because analysts weren’t thorough. They surface because the methodology was designed for the wrong kind of search. If you’re planning a product launch, entering a new market, or preparing for a licensing discussion and want to know whether the FTO analysis you’re working from actually covers the right risks, that’s a question worth pressure-testing before the stakes get higher.
Learn more about how GreyB approaches FTO search here: https://greyb.com/services/patent-search/freedom-to-operate-search/